Denver St. Lukes Presbyterian is a clinical research site located in Denver, Colorado, United States.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Denver St. Lukes Presbyterian has participated in 1 clinical trials.
Therapeutic areas: HCMV Reactivation or HCMV End-Organ Disease.
Sponsors: AiCuris Anti-infective Cures AG.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Denver St. Lukes Presbyterian has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Denver St. Lukes Presbyterian has 1 clinical trials on record. Their work covers HCMV Reactivation or HCMV End-Organ Disease.
Denver St. Lukes Presbyterian has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.